JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dickinson, R. G.
Right arrow Articles by Baughman, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dickinson, R. G.
Right arrow Articles by Baughman, W. L.

Nonlinear elimination and cholerteic effect of valproic acid in the monkey

RG Dickinson, SM Taylor, SN Kaufman, RM Rodgers, RK Lynn, N Gerber and WL Baughman

Five adult cynomolgus monkeys (Macaca fascicularis) were each given doses of 15 and 150 mg/kg of sodium valproate on separate occasions through indwelling arterial or venous catheters. Timed samples of blood (0-1440 min) and urine were collected for measurement of free and conjugated valproic acid (VPA). In all animals a brief distribution (alpha) phase, complete by 10 to 15 min, was followed by a biphasic decline in concentration of the drug. The times required for the concentration of VPA in blood at 25 min to decline by 50% were 42.4 +/- 2.6 (S.E.) min and 94 +/- 7.5 (S.E.) min at the 15 and 150 mg/kg doses, respectively. The terminal half-lives (T 1/2) were 345 +/- 46 (S.E.) min and 428 +/- 56 (S.E.) min at the low and high dose, respectively. In contrast to our earlier studies in the rat, surgical exteriorization of the bile did not alter the elimination profile of VPA from the blood of the monkey. Only 3 to 7% of the administered dose of the drug appeared as conjugated VPA in the bile (c.f. 60% in the rat), thereby confirming that enterohepatic circulation of VPA was of minor importance in determining the pattern of elimination of the drug from blood in the monkey. Urinary excretion of conjugated VPA in intact and bile-exteriorized monkeys totaled 56 and 52% of the 15 mg/kg dose and 60 and 63% of the 150 mg/kg dose, respectively. In monkeys, as in rats, sodium valproate caused a dose-dependent, immediate choleretic reponse, the duration of which followed the blood concentration of the drug.

Volume 213, Issue 1, pp. 38-48, 04/01/1980
Copyright © 1980 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
I. Spriet, W. Meersseman, E. De Troy, A. Wilmer, M. Casteels, and L. Willems
Meropenem -valproic acid interaction in patients with cefepime-associated status epilepticus
Am. J. Health Syst. Pharm., January 1, 2007; 64(1): 54 - 58.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. W. E. Wright and R. G. Dickinson
Abolition of Valproate-Derived Choleresis in the Mrp2 Transporter-Deficient Rat
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 584 - 588.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
N. Yamamura, K. Imura, H. Naganuma, and K. Nishimura
Panipenem, A Carbapenem Antibiotic, Enhances the Glucuronidation of Intravenously Administered Valproic Acid in Rats
Drug Metab. Dispos., June 1, 1999; 27(6): 724 - 730.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics.